CorVel Corporation

NASDAQ:CRVL

Insurance - Brokers

Financial Services
$88.87 -0.12%

-$0.07 today

Market cap
$4.47B
Beta
0.98
P/E (TTM)
26.9
EPS (TTM)
$2.16
52W Low $44.83High $105.51

Volume 0.26M

Average 0.22M

CRVL Other Income / Expenses

Net non-operating gains and losses, such as investment results, currency effects, and one-off items.

CorVel CorporationNASDAQ: CRVL

Other Income / Expenses · Q2 FY2027 · quarter ended Sep 2026

Other income / expenses remains negative

Q2 FY2027 other income / expenses was $0, compared with $0 a year earlier. Trailing-twelve-month other income / expenses was $0.

Context

  • Other income / expenses amounted to 0.0% of revenue in FY2026, unchanged from a year earlier.
  • Other income / expenses increased in 0 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly other income / expenses holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
$0— QoQ
Last fiscal yearMar 2026
$0— YoY
LTMSep 2026
$0— YoY
Other Income / Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Income / Expenses history

USD · from the income statement

Latest · FY2026
0 USD
Year-over-year change
—

Other Income / Expenses vs competitors

How CRVL compares with its peers on the latest reported figures

  • CRVL's LTM Sep 2026 other income / expenses of $0 is the highest of the 4 companies compared; the peer median is -$370.71M.
  • Other income / expenses amounts to 0.0% of revenue for CRVL, versus a peer median of 25.5%.
CRVL Competitors Peer median
Other Income / Expenses for CRVL and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CRVLCorVel CorporationLTM Sep 2026$0 ——0.0%
HQYHealthEquity, Inc.LTM Jul 2026-$40.16M +65.3%—2.9%
CTEVClaritev CorporationLTM Mar 2026-$370.71M +8.5%—37.9%
EVHEvolent Health, Inc.LTM Mar 2026-$480.92M -495.4%—25.5%
Peer median (excluding CRVL) -$370.71M+8.5%—25.5%

Competitors are the stored peer set for CRVL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Mar 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Revenue646.23M718.56M795.31M895.59M958.53M
Cost of Revenue494.12M560.3M623.62M685.86M725.66M
Gross Profit152.11M158.26M171.69M209.73M232.86M
Gross Margin23.5%22.0%21.6%23.4%24.3%
Research & Development00000
Selling, General & Admin67.6M73.71M76.59M88.9M89.73B
Operating Expenses67.6M73.71M76.59M88.9M89.73M
Depreciation & Amortization23.92M25.12M26.25M29.54M31.76M
EBITDA108.43M109.68M121.35M150.36M174.9M
EBITDA Margin16.8%15.3%15.3%16.8%18.2%
Operating Income84.51M84.55M95.1M120.82M143.13M
Operating Margin13.1%11.8%12.0%13.5%14.9%
Interest Income00000
Interest Expense00000
Other Income / Expenses00000
Income Before Tax84.51M84.55M95.1M120.82M143.13M
Pre-Tax Margin13.1%11.8%12.0%13.5%14.9%
Income Tax Expense18.1M18.19M18.85M25.66M32.79M
Net Income66.41M66.37M76.25M95.17M110.34M
Net Margin10.3%9.2%9.6%10.6%11.5%
EPS (Basic)1.251.281.481.852.15
EPS (Diluted)1.221.261.471.832.14
Weighted Avg Shares53.26M51.98M51.37M51.39M51.28M
Weighted Avg Shares (Diluted)54.38M52.78M52.04M52.04M51.63M

CorVel Corporation

NASDAQ:CRVL

Intrinsic Alpha fair value

Locked

Current Price

$88.87

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.